08 November, 01:45
https://www.biopharmadive....
The latest developments on the gene therapy frontier
Gene therapy is once again at the forefront of biomedical research, catalyzed by advances in safer delivery of genes to cells. Science may also move quickly past gene replacement therapy to gene editing via CRISPR and other methods, an approach in which the unknowns are even greater and clinical results are just beginning to emerge.
#genetherapy #genetictherapy
The latest developments on the gene therapy frontier
Gene therapy is once again at the forefront of biomedical research, catalyzed by advances in safer delivery of genes to cells. Science may also move quickly past gene replacement therapy to gene editing via CRISPR and other methods, an approach in which the unknowns are even greater and clinical results are just beginning to emerge.
#genetherapy #genetictherapy
Gene Therapy | BioPharma Dive
BioPharma
https://www.biopharmadive.com/trendline/gene-therapy/41/?utm_source=BPGT&utm_medium=InlineNov3&utm_campaign=Medrio&utm_content=ad-INLINE_SPOT_1&utm_term=47977
08 November, 01:43
String of gene therapy deals spurs cautious optimism on Wall Street
To some analysts, the recent acquisitions of Akouos and AGTC, as well as Astellas’ equity investment in Taysha, are a positive signal for the field.
Published Nov. 1, 2022
https://www.biopharmadive....
#genetherapy #genenitc
To some analysts, the recent acquisitions of Akouos and AGTC, as well as Astellas’ equity investment in Taysha, are a positive signal for the field.
Published Nov. 1, 2022
https://www.biopharmadive....
#genetherapy #genenitc
String of gene therapy deals spurs cautious optimism on Wall Street
BioPharma
https://www.biopharmadive.com/news/gene-therapy-deals-acquisitions-akouos-agtc-taysha/635523/?utm_source=Sailthru&utm_medium=email&utm_campaign=Issue:%202022-11-03%20BioPharma%20Dive:%20Gene%20Therapy%20%5Bissue:45767%5D&utm_term=BioPharma%20Dive:%20Gene%20Therapy
